SPDR SERIES TRUST's ticker is KRE and the CUSIP is 78464A698. A total of 505 filers reported holding SPDR SERIES TRUST in Q4 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,455 | -49.3% | 992 | -50.4% | 0.00% | -50.0% |
Q2 2023 | $81,721 | +166.2% | 2,001 | +185.9% | 0.00% | +100.0% |
Q1 2023 | $30,702 | +422.7% | 700 | +600.0% | 0.00% | – |
Q4 2022 | $5,874 | -2.1% | 100 | 0.0% | 0.00% | – |
Q3 2022 | $6,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2022 | $6,000 | -62.5% | 100 | -58.2% | 0.00% | – |
Q1 2022 | $16,000 | -27.3% | 239 | -24.1% | 0.00% | -100.0% |
Q4 2021 | $22,000 | +46.7% | 315 | +46.5% | 0.00% | 0.0% |
Q3 2021 | $15,000 | +7.1% | 215 | -0.5% | 0.00% | 0.0% |
Q2 2021 | $14,000 | -77.8% | 216 | -77.2% | 0.00% | -66.7% |
Q1 2021 | $63,000 | +425.0% | 947 | +154.6% | 0.00% | +200.0% |
Q1 2020 | $12,000 | +71.4% | 372 | +210.0% | 0.00% | 0.0% |
Q4 2019 | $7,000 | -65.0% | 120 | -68.4% | 0.00% | -50.0% |
Q3 2019 | $20,000 | +122.2% | 380 | +99.0% | 0.00% | +100.0% |
Q4 2018 | $9,000 | -18.2% | 191 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $11,000 | -8.3% | 191 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $12,000 | -88.5% | 191 | -88.9% | 0.00% | -91.7% |
Q1 2018 | $104,000 | -57.7% | 1,728 | -58.6% | 0.01% | -60.0% |
Q4 2017 | $246,000 | – | 4,176 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hefren-Tillotson, Inc. | 1,775,216 | $73,103,000 | 33.42% |
XPONANCE, INC. | 771,984 | $31,287,000 | 12.10% |
Yost Capital Management, LP | 230,000 | $9,471,000 | 9.10% |
CHARTIST INC /CA/ | 24,871 | $1,014,000 | 6.21% |
WOOSTER CORTHELL WEALTH MANAGEMENT, INC. | 194,189 | $7,997,000 | 6.00% |
IRON Financial LLC | 169,905 | $6,997,000 | 4.66% |
Verity Asset Management, Inc. | 91,740 | $3,778,000 | 3.78% |
EnTrustPermal Management LLC | 65,700 | $2,706,000 | 3.29% |
United Asset Strategies, Inc. | 139,950 | $5,763,000 | 2.66% |
ELLIOTT MANAGEMENT CORP | 2,950,000 | $121,540,000 | 2.33% |